OpenVSafe by OpenVAERS
Search V-safe

8TA-31860-69712

1 vaccination 1 coded response 7 check-ins 1 free-text entry 0 call cases
Sex
Male
Age at first dose
16-20
ZIP prefix
270 / NC
Registered
2021-09-16
Relationship
Child or adolescent in my care
Guardian
ZTR-11541-42819
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-09-16
    Registered in v-safe
  2. 2021-09-16
    Dose 1 — Pfizer-BioNTech
  3. 2021-09-16
    Health check-in — day 0, dose 1, dependent
    Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do their normal daily activities
    Adult check-in
  4. 2021-09-17
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  5. 2021-09-18
    Survey response — days 1–6 daily, dose 1, dependent
    MedDRA: Pyrexia — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do their normal daily activities
    Free text: Timothy takes Naprosyn 500 daily, should not have fever
    MedDRA releases: 2024-11 · check-in free text available
  6. 2021-09-19
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-09-20
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-09-21
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do their normal daily activities
    Adult check-in
  9. 2021-10-08
    Health check-in — day 21, dose 1, dependent
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-09-16Pfizer-BioNTech No

Free text

Release 9 — days 1–6 daily, dose 1, dependent

2021-09-18

Systemic reaction (other): Timothy takes Naprosyn 500 daily, should not have fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROPyrexia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…